Hanmi Pharm. Co., Ltd.
128940
Rank in Stocks
#4358
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Share Price
$279.16
Market Cap
$3.54B
Change (1 day)
-2.37%
Change (1 year)
14.50%
Country
KR
Trade Hanmi Pharm. Co., Ltd. (128940)
Category
Healthcare
Earnings for Hanmi Pharm. Co., Ltd. (128940)
Earnings in Jun 2026 TTM: $215.70M
According to Hanmi Pharm. Co., Ltd. latest financial reports the company's current earnings are $215.70M. In 2024 the company made an earning of $116.49M, a decrease compared to its 2023 earnings that were of $149.84M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Hanmi Pharm. Co., Ltd. from 2010 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $215.70M | 47.71% |
| 2025 | $146.03M | 25.36% |
| 2024 | $116.49M | -22.26% |
| 2023 | $149.84M | 56.25% |
| 2022 | $95.90M | 9.95% |
| 2021 | $87.22M | 327.88% |
| 2020 | $20.38M | -71.73% |
| 2019 | $72.11M | 59.46% |
| 2018 | $45.22M | -18.10% |
| 2017 | $55.22M | 732.49% |
| 2016 | $6.63M | -96.28% |
| 2015 | $178.34M | 435.24% |
| 2014 | $33.32M | -36.02% |
| 2013 | $52.08M | 72.15% |
| 2012 | $30.25M | 443.59% |
| 2011 | $5.57M | -147.87% |
| 2010 | $-11.63M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $1.72B | 699.10% |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 718.07% |
IN
|
